Agoracom Blog Home

Posts Tagged ‘tsx-v’

Innocan’s $INNO.ca SHIR (TM) Beauty & Science #CBD Derma Cosmetics Products Passed Safety Assessments and Have Been Approved for Marketing in the European Union $GWPH $CRDL.ca $PCLO.ca

Posted by AGORACOM-JC at 4:45 PM on Thursday, August 6th, 2020
Innocan-Blog
  • Announced that its SHIR™ CBD Derma Cosmetic product line, has successfully passed safety assessment in accordance with European Union (EU) cosmetic regulation No 1223/2009 and received a EU Cosmetic Product Safety Report for marketing in the European Union
  • SHIR™ skincare products combine the benefits of CBD with the most effective ingredients in an innovative formula to deliver visible results
  • The SHIR™ Beauty & science products that are approved for marketing in the Europe are: SHIR CBD+ ANTI-AGING Beauty Sleeping Mask ,SHIR CBD MUST Eye Serum, SHIR CBD MUST Recovery Lotion, SHIR CBD MUST Glow Oil, SHIR CBD MUST Face Cream, SHIR CBD+ ANTI-AGING Facial Serum

Herzliya, Israel and Calgary, Alberta–(August 6, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan”), is pleased to announce that its SHIR™ CBD Derma Cosmetic product line, has successfully passed safety assessment in accordance with European Union (EU) cosmetic regulation No 1223/2009 and received a EU Cosmetic Product Safety Report for marketing in the European Union.

SHIR™ skincare products combine the benefits of CBD with the most effective ingredients in an innovative formula to deliver visible results. The SHIR™ Beauty & science products that are approved for marketing in the Europe are: SHIR CBD+ ANTI-AGING Beauty Sleeping Mask ,SHIR CBD MUST Eye Serum, SHIR CBD MUST Recovery Lotion, SHIR CBD MUST Glow Oil, SHIR CBD MUST Face Cream, SHIR CBD+ ANTI-AGING Facial Serum.

Innocan’s SHIR™ Beauty & Science CBD Derma Cosmetics

https://orders.newsfilecorp.com/files/6922/61225_6b37fecc040dc9bd_002full.jpg



To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6922/61225_6b37fecc040dc9bd_002full.jpg

“As a Pharma Company, Innocan is committed to creating premium products that meet the highest quality standards to provide consumer confidence,” Iris Bincovich, co-founder and CEO of Innocan states. “Compliance with EU regulation is a major milestone for us, following the receipt of technical validation from the FDA for the marketing in the US of our over-the-counter Relief & Go Pain Relief spray, a few weeks ago. The next step is to initiate our various distribution platforms to deliver our SHIR™ CBD Derma Cosmetic line across the European Union and other markets where legally permitted to do so.”

About Innocan

The Company, through its wholly owned subsidiary, Innocan Pharma Ltd., is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD”). Innocan and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the COVID-19 Corona Virus using CBD. CBD-Loaded Exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.

The Company signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem to develop a CBD drug delivery platform based on a unique-controlled release Liposome to be administrated by Injection. The Company plans, together with Prof. Berenholtz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University to test the Liposome platform on several potential indications. The Company is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.

For further information, please contact:

For Innocan Pharma Corporation:
Iris Bincovich, CEO
+972-54-3012842
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution regarding forward-looking information

Certain information set forth in this news release, including, without limitation, the effectiveness and safety of the Company’s products, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements. Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

VIDEO – ImagineAR $IP.ca $IPNFF Adds Media Powerhouse Michael Anderson To Spearhead UK & Euro Sales $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 4:30 PM on Thursday, August 6th, 2020
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

If you were a small cap Augmented Reality company from Vancouver that needed to appoint an old media / new media powerhouse to head up your European sales operations, we really don’t think you could have found someone better credentialed than Michael Anderson – and that’s exactly what ImagineAR (IP:CSE) (IPNFF:OTCQB) did.  

Anderson is a highly regarded leader in the world of digital with his roots firmly based in UK media. Part entrepreneur, part corporate animal, he quickly rose through the ranks ending up as Managing Director of News UK. He worked for Rupert Murdoch and Les Hinton during his rise to the top and made the Board room of both News UK and Associated Newspapers (publishers of the Daily Mail).   

Sensing the changing winds of the media business, Anderson was a driving force on the launch team of Metro, which overtook The Sun in 2018 as the largest circulation of any newspaper in the UK.  At Metro, he was instrumental in the paper being cited as a new business case with commercial results not seen previously in the newspaper industry, growing revenue from £100k a week to £1m per week in just 12 months.  Additionally, Mike was the founder of the Chelsea APPS Factory which included UK clients KPMG, Ladbrokes, Standard Life, TfL, Vanquis and Waitrose.    

….. And now he is sensing another change in the winds to put his considerable talents and team behind the Augmented Reality solutions of ImagineAR.  

If you don’t know what Augmented Reality (AR) is, this quote from Apple CEO Tim Cook is all the motivation you need to get up to speed:  

“AR Will play an important role in how we use technology in the future – and promises to be as influential in our society as the smart phone”  

 Anderson wholeheartedly agrees, stating “ImagineAR is the most advanced AR platform in the market today and I am excited to launch the company’s sales and marketing initiatives in the UK and Europe.”  

That quote is just the tip of the iceberg.  Watch what Anderson has to say about the “unlimited possibilities of Augmented Reality” and some pretty good hints about whose doors he will be knocking on first …. which is pretty impressive given the fact August is vacation season in Europe 🙂   

If our interview with CEO Alen Paul Silverrstieen and Michael Anderson is any indication, it sounds like the Company’s growth into the UK and Europe is all but assured in 2020 and well beyond.  

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

Else Nutrition $BABY.ca Provides Corporate Update $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 1:02 PM on Thursday, August 6th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Company’s proprietary, plant based, clean label formula for toddlers will launch in August 2020
  • A full-scale marketing campaign for the launch has commenced with samples and pre-order sales over the past few weeks; the product will be shipped to consumers in the U.S. and Canada from two U.S. based warehouses of a third-party logistics partner
  • The Company’s Amazon.com store will launch in the coming weeks

VANCOUVER, BC /August 6, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company“), a developer of plant-based alternatives to dairy-based baby nutrition, is pleased to provide the following corporate update.

“Our team has been working relentlessly, during an unprecedently difficult time, to bring our product to market. As we get set to launch, we are beyond thrilled to have crossed major hurdles over the past months and weeks – including full scale manufacturing with a U.S. based partner and mobilization of our U.S. supply chain which has culminated in our ability to ship samples of our plant-based formula for toddlers to eager parents across North America,” said Ms. Hamutal Yitzhak, CEO and Co-Founder of Else.

North America Launch

The Company’s proprietary, plant based, clean label formula for toddlers will launch in August 2020. A full-scale marketing campaign for the launch has commenced with samples and pre-order sales over the past few weeks; the product will be shipped to consumers in the U.S. and Canada from two U.S. based warehouses of a third-party logistics partner. The Company’s Amazon.com store will launch in the coming weeks.

U.S. Manufacturing

The first full-scale commercial manufacturing run of the toddler nutrition powder product was successfully completed by the Company’s U.S. manufacturing partner and packed at a co-packer plant in Nevada.

The terms of the U.S. manufacturing agreement have been negotiated and a formal agreement will be executed upon the receipt of final yield and cost optimization parameters. The next commercial manufacturing run is booked and secured.

FDA Regulatory Pathway

The Company in conjunction with its FDA consulting partner continues to progress on the regulatory pathway for multiple products including an infant formula and new products currently in development for the adult nutrition market.

Health and Happiness International Holdings Limited

The Company’s negotiations with its strategic partner, H&H Global, for distribution rights of the toddler and infant formula in France are advancing well. The parties are studying the target market needs, channels, and regulations, in addition to preparing a launch plan and negotiating the distribution terms. Additionally, discussions regarding distribution in additional markets have also commenced.

Cash and Runway

The company is well capitalized, with approximately CAD$7.0 million in cash, and no short or long-term debt, to fully support its manufacturing and go-to-market plans for the next 12 months.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For more information, contact:

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director of Else Nutrition
Email: [email protected]
Telephone: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

White House Fellow (1990-91), Eric Phillips, Joins Binovi Technologies $VISN.ca as a Strategic Advisor $EYPT $KALA

Posted by AGORACOM-JC at 4:16 PM on Wednesday, August 5th, 2020
http://www.smallcapepicenter.com/binovi%20square.png
  • Announced the engagement of 1990-91 White House Fellow, Eric Phillips, as a strategic advisor to assist with the commercialization of the Binovi Product Platform within government installations
  • “We are extremely privileged to have Mr. Phillips join the company in an official Advisory capacity. He has been following our progress and is excited to join the company at a time when he can make great impact. Our recent acquisition of the VIMA Rev ballistic grade strobe technology is a perfect opportunity to leverage his impressive political relationships. He is an incredibly creative and intelligent problem solver and we are a better company with him on our team.” stated Adam Cegielski, Binovi Founder & CEO.

Toronto, New York – August 5, 2020 – Binovi Technologies Corp., (Binovi) (TSXV:VISN) | (OTC:BNVIF) announces the engagement of 1990-91 White House Fellow, Eric Phillips, as a strategic advisor to assist with the commercialization of the Binovi Product Platform within government installations.

“I look forward to bringing my political and regulatory expertise to Binovi Technologies in order to advance the company’s goals in commercializing the Binovi Platform products within a number of areas overseen by the various levels of government. It is imperative to understand the intricacies of these processes when dealing with matters of health and safety.” said Eric Phillips, 1990-91 White House Fellow, Strategic Advisor.

About Eric Phillips 1990-91 WHF, MBA, CTP, BSc. Engineering

A former Advisor on Sustainable Development for the Government of Guyana, and the CEO of the Green Guyana Expo and International Business Summit, Mr. Phillips has served internationally as Chairman of the Board, CEO, MD, VP, COO, Program Director, and Engineer in seven countries. In the USA, he launched his career as the Project Manager at AT&T Bell Laboratories for the $15B FTS2000 integrated telecommunication project which allowed him, among other factors, to successfully compete to become a 1990-91 White House Fellow. Eric was the only Caribbean educated Fellow of the 700 that have been appointed at that time. A recent recipient of the Golden Arrow of Achievement National Award, Mr. Phillips has lectured in the School of Entrepreneurship and Business Innovation (SEBI) at the University of Guyana.

Mr. Phillips holds a BSc in Chemical Engineering from McMaster University and an MBA in Marketing and International Business. He was also selected as one of fourteen fast-tracked MBA-Engineers to spend fourteen months at Stevens Institute of Technology and AT&T Bell Laboratories in the Communications Training Program (CTP) for Telecommunications Engineering.

He is the Chairman of The esseQuibo Group Inc., a consulting firm that advises Guyana Goldfields Inc. (TSX:GUY) which has recently been acquired by Zijin Mining Group Co., Ltd (SSE: 601899) (SEHK: 2899) for $323M CAD. Eric has been the Managing Director of AT&T (NYSE:T) Africa &The Middle East, Vice President of AT&T Network Systems, the Managing Director for AT&T Central Europe (Ukraine) and the Deputy Director for AT&T Globalization in Europe. He was also a Director of ASC Inc. in London, United Kingdom. Politically, Eric was the Co-Founder of the REFORM Group in Guyana and the co-Author of the Guyana 21 Plan, a blueprint for Guyana’s National Development.

Eric spent seven years in South Africa where he was a Director for Africa Union Holdings, a Director for Combination Therapy Medical Solutions and the COO for Safika Holdings Pty. Eric has won many awards including: the AT&T Senior VP Award (1993); the Bell Labs Outstanding Service Award (1990); and the Scientific Achievement Award for Apollo Technologies in 1982. He has been featured on the cover of Business Week International and Black Engineering Magazines. He was nominated for the United States Black Engineer of the Year Award for his work on FTS-2000.

Eric Phillips is an author and charitable leader holding interest in the advancement of global education and sport. In June of 2015, Eric was appointment by FIFA to manage Guyana’s football development.

“We are extremely privileged to have Mr. Phillips join the company in an official Advisory capacity. He has been following our progress and is excited to join the company at a time when he can make great impact. Our recent acquisition of the VIMA Rev ballistic grade strobe technology is a perfect opportunity to leverage his impressive political relationships. He is an incredibly creative and intelligent problem solver and we are a better company with him on our team.” stated Adam Cegielski, Binovi Founder & CEO.

Electrik Dojo Agreement

The Company also announces that it has retained Electrik Dojo for US$60,000 for a term of 30 days. Electrik Dojo has been engaged for advisory services for increasing brand awareness for the Company. Electrik Dojo has been engaged for native advertising and digital marketing services for the Company. Certain services to be provided by Electrik Dojo are anticipated to include ‘investor relations activities’ under the policies of the TSX Venture Exchange and applicable securities laws. The Company will continue to look at strategic consultants to expand awareness of the Company and its activities.

For additional information on the Company, please visit https://www.binovi.com/investor-reports/

About Binovi Technologies Corp.

Binovi is a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance. Binovi combines hardware, software, specialized expert knowledge, and unique data insights to deliver customized, one-on-one training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. Binovi is currently used in over 1,500 locations across 20 countries.

Terry Booth

Executive Chairman

Adam Cegielski

Founder | CEO

Tania Archer

Head – Global Marketing | Commercialization | Partnerships

Investor Relations

Email: [email protected]

Toll-free: 1 (844) 866-6162

Forward looking information:

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

ImagineAR $IP.ca $IPNFF Receives Additional $1,000,000 From Exercise Of Warrants For A Total Of Approximately $4.5M In 2020. Launches Moderated Forum On AGORACOM

Posted by AGORACOM-JC at 7:04 AM on Friday, July 31st, 2020
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg
  • Announced the receipt of approximately $4,571,000 from the exercise of 34,207,000 warrants in 2020 up to July 29, 2020
  • Company expects to generate meaningful revenue from its current and anticipated sales pipeline over the next 12 months, as well as, receive additional proceeds from further anticipated warrant exercises
  • Company has also launched a “CEO Verified” Discussion Forum on AGORACOM to serve as the Company’s primary social media platform to interact with both current and prospective shareholders in a fully moderated environment

VANCOUVER, BC and ERIE Pa., July 31, 2020 – ImagineAR Inc. (CSE: IP) (OTCQB: IPNFF) (“ImagineAR” or “Company”) an Augmented Reality Company that enables sports teams, businesses, retailers and organizations to instantly create their own AR mobile campaigns, is pleased to announce the receipt of approximately $4,571,000 from the exercise of 34,207,000 warrants in 2020 up to July 29, 2020.

Today’s announcement and new total receipts from warrant exercises was preceded by announcements on July 8th, in which the Company announced the receipt of approximately $1,500,000 from the exercise of warrants, followed by an announcement on July 20th of an additional $2,000,000 for a new total of approximately $3,500,000.

FINANCIAL RESOURCES ALLOW IMAGINEAR TO PURSUE ALL AUGMENTED REALITY OPPORTUNITIES

The proceeds from this latest round of warrant exercises is expected to provide ImagineAR with the financial resources necessary to fund growth and operations for a minimum of 30 months, assuming the Company wasn’t able to generate any further revenue from business operations.

However, as the Company expects to generate meaningful revenue from its current and anticipated sales pipeline over the next 12 months, as well as, receive additional proceeds from further anticipated warrant exercises, the Company is confident it now has the war chest necessary to pursue all anticipated business opportunities as the demand for its Augmented Reality solutions continues to grow on a weekly basis. 

“Today’s announcement significantly bolsters our financial strength and resources necessary to execute our business plan,” said Paul Silverrstieen, CEO of ImagineAR.  “The continued support and confidence of our valued shareholders is deeply appreciated as we aggressively pursue our growth strategy in 2020 and beyond.”

IMAGINEAR LAUNCHES VERIFIED FORUM ON AGORACOM – FIRST ROUND OF Q&A TO BE POSTED TODAY

The Company has also launched a “CEO Verified” Discussion Forum on AGORACOM to serve as the Company’s primary social media platform to interact with both current and prospective shareholders in a fully moderated environment.

AGORACOM Verified Forums provide the first ever identity verification of small cap company executives on an investor platform.  As a result, ImagineAR’s CEO and officers can post within a discussion forum without the risk of impersonation, while providing shareholders with the confidence of receiving verified information directly from the Company. 

Most importantly, by engaging and communicating in an open forum free for anyone to view, the ImagineAR Verified Forum provides investors will full transparency and equal access to information, without the trolling, profanity and nonsense of unmoderated forums and social media platforms.

Silverrstieen added “Given the growth of the Company in 2020, the demand for engagement and discussion by investors has also grown to the point that it now makes sense to unify these discussions under one umbrella. AGORACOM provides verification of ImagineAR management, as well as, smart rules of engagement to insure civilized, constructive and robust conversation between all of our stakeholders.  It will become an invaluable tool given our anticipated developments in 2020 and I look forward to posting our first Q&A later today.” 

The ImagineAR Forum can be found at https://agoracom.com/ir/Imaginear/forums/discussion 

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders. 

About ImagineAR 

ImagineAR Inc. (IP:CSE) (IPNFF:OTCQB) is an augmented reality (AR) platform, ImagineAR.com, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies. The AR Platform is available as an SDK Plug-in for existing mobile apps. 

All trademarks of the property of respective owners. 

ON BEHALF OF THE BOARD 

Alen Paul Silverrstieen
President & CEO
 

(818) 850-2490
https://twitter.com/IPtechAR
https://www.facebook.com/imaginationparktechnologies
https://www.instagram.com/iptechar
https://www.linkedin.com/company/imagination-park-technologies-inc 

We encourage you to do your own due diligence and ask your broker if Imagine AR Inc. (cse: IP) is suitable for your particular investment portfolio*. 

The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward looking information is based on certain key expectations and assumptions made by Imagine AR management. Although Imagine AR believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because Imagine AR can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and Imagine AR disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

New Age Metals $NAM.ca Recommences Drilling and Environmental Studies at River Valley Palladium Project Near Sudbury $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 9:01 AM on Thursday, July 30th, 2020
  • The River Valley Project is one of North America’s largest undeveloped primary Palladium projects. The Project has excellent infrastructure and is within 100 km of the Sudbury Metallurgical Complex. The Project is 100% owned by New Age Metals
  • The Company contracted Jacobs & Samuel Drilling Ltd of Val Caron, Ontario to conduct a Phase 2, 750 metre drill program at the River Valley Project and drilling has begun
  • July 23, 2020 palladium spot price is US$2,095/oz. As such the basket-price of the payable metal suite at River Valley, which includes palladium, platinum, gold, copper, nickel, and cobalt is priced significantly higher than the pricing used in the 2019 Preliminary Economic Assessment

July 30, 2020 – Rockport, Canada – New Age Metals Inc. (TSXV:NAM); (OTC:NMTLF); (FSE:P7J.F) Harry Barr, Chairman & CEO, stated; “New Age Metals is pleased to announce that the company commenced the next phase of drilling at the River Valley Palladium deposit near Sudbury, Ontario. The company plans to drill about 750 m of core in three holes to test high-priority targets adjacent to the Pine Zone and Dana North Zone of the River Valley deposit. This drill program is the second phase of our 2020 exploration and development program, and will run through August.”

The objectives of the Phase 2 drill program are threefold: 1) in-fill a gap in the previous drilling of the T3 target; 2) expand the T3 target along strike and southwards, and 3) test an undrilled IP chargeability high along 300 metres along strike from the Pine Zone. The T3 target is located downdip/down-plunge of the Pine Zone, in the footwall to the Dana North Zone. Additional information can be found in the various press releases on the New Age Metals website.

The Phase 2 program also includes environmental baseline studies being conducted underway by Story Environmental. This year’s data collection program includes: collecting and analyzing two rounds of surface water samples in low- and high-flow conditions, conducting flow measurements at two local sites, and conducting a fish community and habitat survey. The baseline program data collection may continue into Q4 2020, depending on progress and field conditions.

In addition to the environmental baseline studies, the Phase 2 program also includes a Stage 1 Archaeological Assessment within the River Valley Palladium Project area.


About the River Valley Palladium Project

The details of the updated Mineral Resource Estimate (MRE) and Preliminary Economic Assessment (PEA) were announced in the press release dated August 9, 2019 and are described on NAM’s website. The pit constrained Updated Mineral Resource Estimate formed the basis of the PEA. At a cut-off grade of 0.35 g/t PdEq, the Updated Mineral Resource Estimate contains 2.867 Moz PdEq in the Measured plus Indicated classifications and 1.059 Moz PdEq in the Inferred classification. The PEA is a preliminary report, but it demonstrates that there are potentially positive economics for a large-scale mining open pit operation, with 14 years of Palladium production. Refer to the NAM website (www.newagemetals.com) for details.

Investor Awareness Update

New Age Metals is pleased to announce that the Company will be participating in September’s Global Mining Symposium and November’s Precious Metals Summit Europe, along with some of the most prominent names in the mining industry. Further information about NAM’s participation and schedule at the event will be provided when available. The Company is evaluating other opportunities to increase investor awareness and to leverage the virtual conference platforms widely available to access markets outside of North America and Europe, in which we have previously been active.

Stock Option Grant

In addition, the Company announces that it has granted 2,000,000 incentive stock options to directors, officers and consultants of the Company at an exercise price of $0.10 per share for a period of five (5) years from the date of grant in accordance with the Company’s Stock Option Plan. The Stock Options granted will be subject to vesting restrictions, acceptance by the TSX Venture Exchange and will be subject to regulatory hold periods in accordance with applicable Canadian Securities Laws.

Opt-in List

If you have not done so already, we encourage you to sign up on our website (www.newagemetals.com) to receive our updated news.

About NAM

New Age Metals is a junior mineral exploration and development company focused on the discovery, exploration and development of green metal projects in North America. The Company has two divisions; a Platinum Group Metals division and a Lithium/Rare Element division. The PGM division includes the 100% owned River Valley Project, one of North America’s largest undeveloped Platinum Group Metals Projects, situated 100 km from Sudbury, Ontario as well as the Genesis PGM Project in Alaska. The Lithium division is the largest mineral claim holder in the Winnipeg River Pegmatite Field, where the Company is exploring for hard rock lithium and various rare elements such as tantalum and rubidium. Our philosophy is to be a project generator with the objective of optioning our projects with major and junior mining companies through to production. The Company is actively seeking an option/ joint venture partner for its road-accessible Genesis PGM project in Alaska and for our Lithium division in Manitoba.

New Age Metals is a junior resource company on the TSX Venture Exchange, trading symbol NAM, OTCQB: NMTLF; FSE: P7J with 138,854,511 shares issued to date.

Investors are invited to visit the New Age Metals website at www.newagemetals.com where they can review the company and its corporate activities. Any questions or comments can be directed to [email protected] or Harry Barr at [email protected] or Cody Hunt at [email protected] or call 613 659 2773.

Qualified Person

The contents contained herein that relate to Exploration Results or Mineral Resources is based on information compiled, reviewed or prepared by Bill Stone, P.Geo., a consulting geoscientist for New Age Metals. Dr. Stone is the Qualified Person as defined by National Instrument 43-101 and has reviewed and approved the technical content of this news release.

On behalf of the Board of Directors

Harry Barr”

Harry G. Barr

Chairman and CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Statements: This release contains forward-looking statements that involve risks and uncertainties. These statements may differ materially from actual future events or results and are based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. In addition, forward-looking statements include statements in which the Company uses words such as “continue”, “efforts”, “expect”, “believe”, “anticipate”, “confident”, “intend”, “strategy”, “plan”, “will”, “estimate”, “project”, “goal”, “target”, “prospects”, “optimistic” or similar expressions. These statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others, the Company’s ability and continuation of efforts to timely and completely make available adequate current public information, additional or different regulatory and legal requirements and restrictions that may be imposed, and other factors as may be discussed in the documents filed by the Company on SEDAR (www.sedar.com), including the most recent reports that identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company does not undertake any obligation to review or confirm analysts’ expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Investors should not place undue reliance on forward-looking statements.

VIDEO – Empower Clinics $CBDT.ca Grows Revenue 416% To $USD 790,000 In Q1 – BEFORE COVID-19 Revenues Commenced In Q2 $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 5:36 PM on Wednesday, July 29th, 2020

Sometimes, you just have to let the numbers speak for themselves.  With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for …

but then these numbers came in for:   2019 – Year Ended DEC 31, 2019 Q4 – Quarter Ended DEC 31, 2019 Q1 – Quarter Ended MAR 31, 2020  

Patient Visits

  • 2019 +110% To 15,900
  • Q4 + 251% To 4,616
  • Q1 + 377% To 5,717 (PRE COVID REVENUES COMMENCING Q2)

Revenues $USD

  • 2019 + 86% To $2.03M
  • Q4 + 217% To $625,000
  • Q1 + 416% To $790,000  (PRE COVID REVENUES COMMENCING Q2)  

Do you see a trend?   

We can’t wait for Q2 numbers (April, May, June) because we already know patient visits for April alone were up over 870%.   

Looking even further forward into Q3 (July, August, September), we already know that July patient visits are going to set a record.    

Though CBDT had a very short cease trade order due to the delay in getting these financials filed…. the wait was clearly worth it, as was this interview with CEO, Steven McAuley,  who is Six Sigma certified under the quality initiative of legendary GE (General Electric) Chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history and turn it into significant growth.  

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

VIDEO – New Age Metals $NAM.ca 2.9M Ounces Of Palladium Equivalent Is Why Eric Sprott Owns 18.5% $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 5:14 PM on Wednesday, July 29th, 2020

Three years ago, Harry Barr couldn’t get anyone to even look at New Age Metals (NAM:TSXV) flagship property, the 100% owned River Valley Project, one of North America’s largest undeveloped Platinum Group Metals Projects, situated 100 kilometres from Sudbury.  

But with Palladium at $US 2,100/oz and River Valley sitting on 2.9Moz Palladium Equivalent (Measured & Indicated), things have changed significantly, including the fact that  Eric Sprott has become a strategic shareholder with 18.56% ownership.  

WAIT … THERE’S MORE  

NAM’s 2019 Preliminary Economic Assessment highlights include a 14 year mine life, resulting in an annual average payable Palladium Equivalent production of 119,000 ounces.  

WAIT ….. THERE’S ONE MORE THING  

The PEA assumed a Palladium price of $US 1,200, which is now 75% higher at $US 2,100.   With NAM now using their war chest to further drill River Valley and follow-up on recommendations from the PEA, there is reason to believe this story is only going to get better.  

Grab your favourite beverage and watch this interview with NAM CEO, Harry Barr.

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

PyroGenesis $PYR.ca Announces Q2 2020 Results: Net Income $5.2MM; Gross Margin 60%; Earnings per Share $0.04 $RTN $NOC $UTX $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 8:57 AM on Wednesday, July 29th, 2020

Q2 2020 results reflect the following highlights:

  • Revenues of $2,128,454, an increase of 133% from $913,769 posted in Q2 2019
  • Comprehensive income of $5,228,020 an increase of 332% from ($2,253,390) posted in Q2 2020
  • Gross margin of 59.5% an increase of 39.2% over the same period in Q2 2019
  • Cash on hand on June 30, 2020 was $1,567,777 (December 31, 2019: $34,431)
  • Backlog of signed contracts as of the date of this writing is approx. $28MM.
  • Management expects significant revenue growth in 2020

MONTREAL, July 29, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, is pleased to announce today its financial and operational results for the second-quarter ended June 30th, 2020.

“Percent complete revenue recognition in our major projects, which is the revenue recognition method we are mandated to follow by GAAP, is such that it is not linear, but exponential and as such, Q2 is now starting to reflect the results one might expect given recent announcements. It is interesting to note that using this revenue recognition method, only $1.8MM has been recognized under the $22MM+ DROSRITE™ contract for which we have announced receipt of over $7MM, and which will be completed within the next year. Using this same revenue recognition method, we can provide guidance for Q3 2020, and for the year ending December 31st, 2020: At this point, we expect that Q3 2020, and the nine months ending September 30, 2020, will both be profitable as will year end results. We are projecting Q3 2020 EPS (Basic & Diluted) to be conservatively in excess of 6 cents,” said P. Peter Pascali, CEO and President of PyroGenesis. “We are happy to be reporting these results in record time, and are pleased to note that we did so within the time frame set by more demanding exchanges. As such, we have set a goal to report all future financial results within the more stringent requirements set by the TSX as opposed to the TSXV.”

Q2 2020 results reflect the following highlights:

  • Revenues of $2,128,454, an increase of 133% from $913,769 posted in Q2 2019
  • Comprehensive income of $5,228,020 an increase of 332% from ($2,253,390) posted in Q2 2020
  • Gross margin of 59.5% an increase of 39.2% over the same period in Q2 2019
  • Cash on hand on June 30, 2020 was $1,567,777 (December 31, 2019: $34,431)
  • Backlog of signed contracts as of the date of this writing is approx. $28MM.

Management Guidance for Q3 2020

  • Management expects significant revenue growth
  • Management expects that Q3 2020 and the nine months ending September 30, 2020 to be profitable
  • Earnings per Share (EPS) > $0.06.

Management Guidance for full year 2020:

  • Management expects significant revenue growth in 2020
  • Earnings per Share (EPS) > $0.10.

OUTLOOK

Percent complete revenue recognition in our major projects, which is the revenue recognition method we are mandated to follow by GAAP, is such that it is not linear, but exponential and as such, Q2 is now starting to reflect the results one might expect given recent announcements. It is interesting to note that using this revenue recognition method, only $1.8MM has been recognized under the $22MM+ DROSRITE™ contract for which we have announced receipt of over $7MM, and which will be completed within the next year.

Using this same revenue recognition method, we can provide guidance for Q3 2020, and for the year ending December 31st, 2020: At this point we expect that Q3 2020, and the nine months ending September 30, 2020, will both be profitable as will year end results. We are projecting Q3 2020 EPS (Basic & Diluted) to be conservatively in excess of 6 cents and the year to be in excess of 10 cents. 

Any discussion regarding the OUTLOOK of the company would be remiss if it did not address the continued increase in the Company’s market capitalization and the implications that has for the future.

Without a doubt the Company’s market capitalization suffered, as did many other companies, in the general Covid-19 market meltdown at the end of March 2020. However, PyroGenesis soon broke from the pack with the issuance of a material press release on March 24th, 2020.

Management believes that its breaking from the ranks caught the attention of investors, fund managers, and money managers who all now had the time during the COVID-19 lockdown to fully analyze the complicated story that is PyroGenesis. Management does not see any reason why this interest would abate anytime soon. To the contrary, Management has reason to believe that interest in the Company will only increase over the foreseeable future. As such, several strategies (up listings, spinoffs, acquisitions) are now being accelerated/considered.

Having a larger market capitalization has also helped in discussions with potential customers who take comfort from the possibility that a higher market capitalization may translate into easier access to capital. For the record, there is no intention to raise capital for working capital purposes.

If 2018 was the year in which PyroGenesis successfully positioned each of its commercial business lines by strategically partnering with multi-billion-dollar entities, and 2019 was the year that saw the appropriate personnel and infrastructure being put in place while building upon the success of 2018, then 2020 is without a doubt the year that  the long awaited breakout, which began in the second half of 2019, takes place; it is in fact already upon us:

To date during 2020, PyroGenesis has:

  1. received significant payments under the $22MM contract with Drosrite International thereby validating announcements made during 2019,

  2. established a relationship with a US based tunneling company (contracts and payments ongoing),

  3. Established itself in the iron ore pelletization industry as a potential supplier of torches geared to replacing existing burners and thereby reducing GHGs. Interest is also spilling over into other industries with GHG reduction targets,

  4. Established a relationship with an OEM in North America with the intent to eventually supply powders for their 3D printing needs. This augments our relationship with Aubert & Duval, while at the same time de-risking our dependence on them,

  5. retired the $3MM convertible debenture in full,

  6. bought back approximately 1.2 Million shares under the existing Normal Course Issuer Bid,

  7. increased Company’s investment in HPQ, who has subsequently also experienced a significant increase in market capitalization,

  8. further benefited from early conversions of warrants maturing in 2021 of over $3MM. 

The Company has booked a significant backlog of signed contracts (in excess of $28MM; 2019 Revenues approx. $5MM) which, when taking the eagerly awaited US Navy contract into account, will increase to over $38MM. This provides a solid cornerstone upon which PyroGenesis can:

  1. continue to build on the recent successes with the Company’s DROSRITE™ offering,

  2. Leverage off of the recent successes with the Company’s torch offerings to (i) the iron ore pelletization industry, and (ii) a tunneling client,

  3. Accelerate activities with Aubert & Duval in the Additive Manufacturing sector as well as HPQ in the Mining and Metallurgical sector, both of which did not progress as fast as management would have liked in 2019. Significant attention will be placed on both these activities in 2020.

Specifically, with Aubert & Duval the goal will be to complete the integration of the cutting-edge advances PyroGenesis has made to the powder production process.

With respect to HPQ, the goal would be to accelerate the game changing PUREVAP™ family of processes which we are developing for HPQ, namely:

  • The PUREVAP™ “Quartz Reduction Reactors” (QRR), an innovative process (patent pending), which will permit the one step transformation of quartz (SiO2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential; and
  • The PUREVAP™ Nano Silicon Reactor (NSiR), a new proprietary process that use PUREVAP™ QRR silicon (Si) as feedstock, to make spherical silicon nano powders and nanowires;

Looking forward, the Company has, as of December 31st, 2019, approximately $10MM of in-the-money warrants and options expiring in 2020 and 2021. The Company also has over $50MM in tax loss carryforwards (roughly evenly distributed between federal and provincial obligations) which is not reflected as an asset on the balance sheet. 

Financial Summary

Revenues

PyroGenesis recorded revenue of $2,128,454 in the second quarter of 2020, representing an increase of 133% compared with $913,769 recorded in the second quarter of 2019.

Revenues recorded in the three and six months ended June 30, 2020 were generated primarily from:

  1. DROSRITE™ related sales of $1,319,904 (3 months) and $1,794,336 (6 months),
  2. PUREVAP™ related sales of $25,093 (3 months) and $43,058 (6 months),
  3. torch related sales of $617,077 (3 months) and $705,022 (6 months),
  4. support services related to PAWDS-Marine systems supplied to the US Navy $37,143 (3 months) and $61,039 (6 months).

Cost of Sales and Services and Gross Margins

Cost of sales and services before amortization of intangible assets was $855,049 in Q2 2020, representing an increase of 18% compared with $723,641 in Q2 2019, primarily due to an increase in subcontracting and direct material expenses offset by a reduction in employee compensation in Q2 2020.

In Q2 2020, employee compensation decreased to 103,957 (Q2 2019 – $414,873) and subcontracting, direct materials and manufacturing overhead increased to $813,201 (Q2 2019 – $335,240). The gross margin for Q2 2020 was $1,268,592 or 59.5% of revenue compared to a gross margin of $185,349 or 20.3% of revenue for Q2 2019. As a result of the type of contracts being executed, the nature of the project activity, as well as the composition of the cost of sales and services, as the mix between labour, materials and subcontracts may be significantly different. Of note, the Company in Q2 2020 applied for an amount of $648,125 in wage subsidy from Revenue Canada under the CEWS program. From this amount, $92,028 was applied to employee compensation under cost of sales and services.

Investment tax credits recorded against cost of sales are related to projects that qualify for tax credits from the provincial government of Quebec. Qualifying tax credits decreased to $18,758 in Q2 2020, compared with $29,061 in Q2 2019. This represents a decrease of 35% year-over-year. In total, the Company earned refundable investment tax credits of $17,332 in Q2 2020. The Company continues to make investments in research and development projects involving strategic partners and government bodies.

The amortization of intangible assets of $6,813 in Q2 2020 and $4,779 for Q2 2019 relates to patents and deferred development costs. Of note, these expenses are non-cash items and will be amortized over the duration of the patent lives.

Selling, General and Administrative Expenses

Included within Selling, General and Administrative expenses (“SG&A”) are costs associated with corporate administration, business development, project proposals, operations administration, investor relations and employee training.

SG&A expenses for Q2 2020 excluding the costs associated with share-based compensation (a non-cash item in which options vest principally over a four-year period), were $1,641,338 representing an increase of 4% compared with $1,583,779 reported for Q2 2019. 

The increase in SG&A expenses in Q2 2020 over the same period in 2019 is mainly attributable to the net effect of:

  • an increase of 34% in employee compensation due primarily to an increase in commission expenses offset by amounts claimed from Revenue Canada under the CEWS wage subsidy program,
  • an increase of 15% for professional fees, primarily due to an increase in legal fees,
  • a decrease of 0.4% in office and general expenses, is due to a decrease in computer and internet expenses,
  • travel costs decreased by 82%, due to a decrease in travel abroad,
  • depreciation on property and equipment decreased by 79% due to lower amounts of property and equipment being depreciated,
  • depreciation on right of use assets decreased by 19% due to lower amounts of right of use assets being depreciated,
  • Investment tax credits increased by 328% due to an additional refund of $24,605 from the 2018 tax return filed,
  • government grants increased by 228% due to higher levels of activities supported by such grants,
  • other expenses decreased by 33%, primarily due to a decrease in cost of freight and shipping.

Separately, share based payments decreased by 14% in Q2 2020 over the same period in 2019 as a result of the vesting structure of the stock option plan including the stock options granted on January 2, 2020.

Research and Development (“R&D”) Costs

The Company incurred ($3,869) of R&D costs, net of government grants, on internal projects in Q2 2020, a decrease of 102% as compared with $212,645 in Q2 2019. The decrease in Q2 2020 is primarily related to an increase in government grants supporting our R&D activities and an amount of $129,201 claimed under the wage subsidy from Revenue Canada under the CEWS program.

In addition to internally funded R&D projects, the Company also incurred R&D expenditures during the execution of client funded projects. These expenses are eligible for Scientific Research and Experimental Development (“SR&ED”) tax credits. SR&ED tax credits on client funded projects are applied against cost of sales and services (see “Cost of Sales” above). 

Net Finance Costs

Finance costs for Q2 2020 totaled $276,928 as compared with $275,418 for Q2 2019, were less than 1%, resulting in a virtually unchanged variance.

Strategic Investments

The adjustment to the fair market value of strategic investments for Q2 2020 resulted in a gain of $5,899,465 compared to a loss in the amount of $339,313 in Q2 2019, representing an increase of 1839% year-over-year. The increase is primarily attributable to the increased market share value in the HPQ Silicon Resources Inc. and Beauce Gold Fields.

Net Comprehensive Loss

The net comprehensive gain for Q2 2020 of $5,228,020 compared to a loss of $2,253,390, in Q2 2019, represents an increase of 332% year-over-year. The increased gain of $7,481,410 in the comprehensive gain in Q2 2020 is primarily attributable to the factors described above, which have been summarized as follows:

  1. an increase in product and service-related revenue of $1,214,685 arising in Q2 2020, an increase in cost of sales and services totaling $133,442, primarily due to an increase in subcontracting, direct materials, manufacturing overhead & other, offset by a decrease in employee compensation,
  2. an increase in SG&A expenses of $53,613 arising primarily due to an increase in employee compensation, professional fees, offset by a decrease in travel, depreciation on property and equipment, depreciation ROU assets, and other expenses,
  3. a decrease in R&D expenses of $216,512 primarily due to an increase in government grants and wage subsidy,
  4. an increase in net finance costs of $1,510 primarily due to interest on higher amounts of debt,
  5. an increase in fair value adjustment of $6,238,778 primarily due to strategic investments.    

EBITDA

The EBITDA gain in Q2 2020 was $5,610,023 compared with an EBITDA loss of $1,814,832 for Q2 2019, representing an increase of 409% year-over-year. The $7,424,855 increase in the EBITDA gain in Q2 2020 compared with Q2 2019 is due to the increase in comprehensive income of $7,418,410, a decrease in depreciation on property and equipment of $38,927, a decrease in depreciation of right of use assets of $21,171, an increase in amortization of intangible assets of $2,034, and an increase in finance charges of $1,511.

Adjusted EBITDA gain in Q2 2020 was $5,633,661 compared with an Adjusted EBITDA loss of $1,787,248 for Q2 2019. The increase of $7,420,909 in the Adjusted EBITDA gain in Q2 2020 is attributable to an increase in EBITDA gain of $7,424,855, offset by a decrease of $3,946 in share-based payments.

The Modified EBITDA loss in Q2 2020 was $265,804 compared with a Modified EBITDA loss of $1,447,935 for Q2 2019, representing a decrease of 82%. The decrease in the Modified EBITDA loss in Q2 2020 is attributable to the increase as mentioned above in the Adjusted EBITDA of $7,357,909 and an increase in the change of fair value of strategic investments of $6,238,778.

Liquidity

The Company has incurred, in the last several years, operating losses and negative cash flows from operations, resulting in an accumulated deficit of $57,304,682 and a negative working capital of $7,463,370 as at Q2 2020, (December 31, 2019 – $60,237,656 and $10,492,102 respectively). Furthermore, as at Q2 2020, the Company’s current liabilities and expected level of expenses for the next twelve months exceed cash on hand of $1,567,777 (December 31, 2019 – $34,431). The Company has relied upon external financings to fund its operations in the past, primarily through the issuance of equity, debt, and convertible debentures, as well as from investment tax credits.

Revenue generated from active projects has begun to produce sufficient positive cash flow to fund operations. The Company has a strong backlog from signed contracts totaling $28MM, and a pipeline of prospective new projects resulting in the Company’s business plan becoming less dependent on raising additional funds to finance operations within and beyond the next 12 months. While the Company has been successful in securing financing in the past, raising additional funds is dependent on a number of factors outside the Company’s control, and as such there is no assurance that it will be able to do so, should it need to, in the future. If the Company is unable to obtain sufficient additional financing when needed, it may have to curtail operations and development activities, any of which could harm the business, financial condition and results of operations.

About PyroGenesis Canada Inc.
PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development
Phone: (514) 937-0002, E-mail: [email protected]
RELATED LINK: http://www.pyrogenesis.com/

Spyder Cannabis $SPDR.ca Announces Final Approvals to Open Niagara Falls and Calgary Cannabis Dispensaries $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 8:40 AM on Wednesday, July 29th, 2020
  • Announced that its dispensary located at 6474 Lundy’s Lane, passed its final inspection on July 27, 2020, and intends to open for business in the first week of August 2020
  • Also announced that its dispensary located at #140, 104 – 58 Avenue SE, was formally issued a Retail Cannabis Store License (No. 781144-1) and intends to open for business in August 2020

Vaughan, Ontario–(July 29, 2020) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company“) and its wholly-owned associated applicants, The Green Spyder Inc. and Spyder Cannabis Subco Inc., is pleased to provide the following update:

Niagara Falls and Cannabis Dispensary

The Company is pleased to announce that its dispensary located at 6474 Lundy’s Lane, passed its final inspection on July 27, 2020, and intends to open for business in the first week of August 2020.

Calgary Cannabis Dispensary

The Company is also pleased to announce that its dispensary located at #140, 104 – 58 Avenue SE, was formally issued a Retail Cannabis Store License (No. 781144-1) and intends to open for business in August 2020.

“Both dispensaries are located in busy commercial hubs, in their respective cities. The Spyder team is excited to commence operations and bring its best of class customer service and retail experience to both cities”, stated Dan Pelchovitz, the Company’s CEO.

About Spyder Cannabis Inc.

Spyder is a Cannabis, Vape and CBD retailer that operates in jurisdictions where the products are federally legal in both Canada and the United States. The Company, through its subsidiaries, is a retailer involved in the development of three retail business units. The first is the sale of Cannabis products, the second is the sale of Hemp CBD in the United States only, the third is the sale of smoking cessation products in Ontario.

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain ‘forward-looking information” within the meaning of applicable securities laws (‘forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.

For additional info, please contact:

Spyder Cannabis Inc.
Dan Pelchovitz
President & Chief Executive Officer
Telephone: 1.888.504.7737
Email: [email protected]